Betamethasone

Thông số

378-44-9Số CAS

206-825-4Số EC

(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-oneTên IUPAC

C22H29FO5Công thức hóa học

392.5 g/molKhối lượng phân tử

betamethasone; 378-44-9; Betadexamethasone; Flubenisolone; Rinderon; Visubeta; Celestene; Betnelan; beta-Methasone; Desacort-Beta; Betametasone; Betametasona; beta-Methasone alcohol; Betamethasonum; SCH 4831; NSC-39470; 9-Fluoro-16beta-methylprednisolone; SCH-4831; 9alpha-Fluoro-16beta-methylprednisolone; DTXSID3022667; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 9842X06Q6M; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-; CHEBI:3077; DTXCID002667; NSC39470; 16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-; Betasolan; (1R,2S,10S,11S,13S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-dien-5-one; (1R,2S,10S,11S,13S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one; (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-3-one; RefChem:5605; A07EA04; C05AA05; D07AC01; D07XC01; H02AB01; R03BA04; S01BA06; S01CB04; S02BA07; S03BA03; 206-825-4; Betamethazone; Betacorlan; Betacortril; Betapredol; Betasolon; Betsolan; Becort; Cidoten; Celestone; Betamamallet; Methazon; Bedifos; Rinderon A; Bebate; Betamethasone (Celestone); MFCD00062969; C22H29FO5; 9a-Fluoro-11b,17a,21-trihydroxy-16b-methylpregna-1,4-diene-3,20-dione; Betamethasone cream; MLS000859943; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.beta.)-; Betamethasone alcohol; Betametasone [DCIT]; NCGC00164401-01; SMR000058601; Betametasona [INN-Spanish]; Betamethasonum [INN-Latin]; (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; .beta.-Methasone; 9-Fluoro-16.beta.-methylprednisolone; Rinderon (TN); .beta.-Methasone alcohol; 9.alpha.-Fluoro-16.beta.-methylprednisolone; 9-alpha-Fluoro-16-beta-methylprednisolone; HSDB 3015; EINECS 206-825-4; NSC 39470; Prednisolone, 9-fluoro-16beta-methyl-; BRN 3176546; Betamethasone RS; UNII-9842X06Q6M; Desacort-.beta.; .beta.-Corlan; Betamethasone CRS; 9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione; NCGC00091019-08; CAS-378-44-9; Prestwick_703; Prednisolone, 9-fluoro-16.beta.-methyl-; 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione; NCS-39470; FLOSTERON; Betamethasone, topical; Betamethasone [USAN:USP:INN:BAN:JAN]; Corticosterone, 1-dehydro-9-fluoro-17-hydroxy-16beta-methyl-; Betamethasone (Standard); Betamethasone, >=98%; Prestwick0_000362; Prestwick1_000362; Prestwick2_000362; Prestwick3_000362; BETAMETHASONE [MI]; CHEMBL632; BETAMETHASONE [INN]; BETAMETHASONE [JAN]; EC 206-825-4; cid_9782; SCHEMBL4565; 16-beta-Methyl-1,4-pregnadiene-9-alpha-fluoro-11-beta,17-alpha,21-triol-3,20-dione; 9-alpha-Fluoro-16-beta-methyl-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione; BETAMETHASONE [USAN]; BIDD:PXR0047; BETAMETHASONE [VANDF]; BSPBio_000483; 4-08-00-03501 (Beilstein Handbook Reference); MLS001066413; MLS001332616; MLS002153244; orb134474; BETAMETHASONE [MART.]; SPBio_002404; BETAMETHASONE [USP-RS]; BETAMETHASONE [WHO-DD]; BETAMETHASONE [WHO-IP]; Corticosterone, 1-dehydro-9-fluoro-17-hydroxy-16.beta.-methyl-; BPBio1_000533; GTPL7061; orb2893733; orb3025860; BDBM73823; 9a-Fluoro-16b-methylprednisolone; Betamethasone (JP18/USP/INN); MSK2230; Betamethasone - Bio-X trade mark; HMS1569I05; HMS2096I05; HMS2233I08; HMS3713I05; BETAMETHASONE [EP IMPURITY]; BETAMETHASONE [ORANGE BOOK]; BETAMETHASONE [EP MONOGRAPH]; Tox21_112115; Tox21_301455; BETAMETHASONE [USP MONOGRAPH]; EBC-11078; HY-13570R; MSK2230-100A; s1500; BETAMETHASONUM [WHO-IP LATIN]; AKOS008901360; AKOS015894863; MSK2230-1000A; Tox21_112115_1; CCG-220362; CS-1897; DB00443; FB18562; KS-5302; 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione; SMP1_000043; NCGC00164401-02; NCGC00164401-03; NCGC00255195-01; (1R,2S,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,10-dihydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; BB300033; HY-13570; BETAMETHASONE DIPROPIONATE IMPURITY A; B1837; Betamethasone 100 microg/mL in Acetonitrile; D1961; NS00073847; DEXAMETHASONE IMPURITY B [EP IMPURITY]; Betamethasone, meets USP testing specifications; C06848; D00244; D88866; EN300-119511; Betamethasone Solution in Acetonitrile, 1000ug/mL; Betamethasone Solution in Acetonitrile, 100ug/mL; Betamethasone, VETRANAL(TM), analytical standard; F814067; Q416132; SR-01000780582; SR-01000780582-2; BETAMETHASONE ACETATE IMPURITY A [EP IMPURITY]; BETAMETHASONE VALERATE IMPURITY A [EP IMPURITY]; BRD-K39188321-001-03-9; Z1521553714; Betamethasone, British Pharmacopoeia (BP) Reference Standard; Betamethasone, European Pharmacopoeia (EP) Reference Standard; Betamethasone, pharmaceutical impurity standard, >=95.0% (HPLC); Betamethasone, United States Pharmacopeia (USP) Reference Standard; (11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; (11b,16b)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; (11beta,16beta)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9-.alpha.-Fluoro-11-.beta.,17,21-trihydroxy-16-.beta.-methylpregna-1,4-diene-3,20-dione; 9-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE.; 9-fluoro-16beta-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione; Betamethasone, Pharmaceutical Secondary Standard; Certified Reference Material; Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-; Pregna-1,4-diene-3,20-dione, 9alpha-fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-; 16-.beta.-Methyl-1,4-pregnadiene-9-.alpha.-fluoro-11-.beta.,17-.alpha.,21-triol-3,20-dione; 9-.alpha.-Fluoro-11-.beta.,17-.alpha.,21-trihydroxy-16-.beta.-methylpregna-1,4-diene-3,20-dione; 9-.alpha.-Fluoro-16-.beta.-methyl-1,4-pregnadiene-11-.beta.,17-.alpha.,21-triol-3,20-dione; 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione, (11.beta.,16.beta.) #; Betamethasone Dipropionate EP Impurity A; Dexamethasone EP Impurity B; Betamethasone Acetate EP Impurity A; Betamethasone Valerate EP Impurity ATên gọi khác